Neurology Edition: Top Headlines for Week of October 31, 2022

In this edition, we bring you news and Healio-exclusive interviews from the American Neurological Association Annual Meeting.

Read the full coverage here:

Optimism in older adults improves functional recovery after stroke

Neurologic, neurocognitive symptoms of COVID-19 persist for 1 year after diagnosis

VIDEO: Functional movement disorders diagnosed on presence of positive criteria

Pain, sleep, mood disorders most common comorbidities in patients with narcolepsy

VIDEO: Gene therapy potential treatment target for Duchenne muscular dystrophy

References:

Chamberlain J, et al. Neurogenetics and gene therapy. Presented at: American Neurological Association annual meeting; Oct. 23-25; Chicago.

Huff HV, et al. The neurologic and neurocognitive sequelae following COVID-19 in Lima, Peru: Presented at: American Neurological Association annual meeting; Oct. 23-25; Chicago.

Lipford MC, et al. Demographic characteristics and comorbidities of patients with narcolepsy: A propensity-score matched cohort study: Presented at: American Neurological Association annual meeting; Oct. 23-25; Chicago.

Reich SG, et al. Updates on functional neurological disorders. Presented at: American Neurological Association annual meeting; Oct. 23-25, 2022; Chicago.

Sloane KL, et al. Always look on the bright side: Associations of optimism with functional outcomes after stroke. Presented at: American Neurological Association annual meeting; Oct. 23-25; Chicago.